Coburn S B, Bray F, Sherman M E, Trabert B
Division of Cancer Epidemiology and Genetics, National Cancer Institute, 9609 Medical Center Drive, Bethesda, MD, 20892.
Cancer Surveillance Section, International Agency for Research on Cancer, 150 cours Albert Thomas, F-69372, Lyon, Cedex 08.
Int J Cancer. 2017 Jun 1;140(11):2451-2460. doi: 10.1002/ijc.30676. Epub 2017 Mar 21.
Internationally, ovarian cancer is the 7th leading cancer diagnosis and 8th leading cause of cancer mortality among women. Ovarian cancer incidence varies by region, particularly when comparing high vs. low-income countries. Temporal changes in reproductive factors coupled with shifts in diagnostic criteria may have influenced incidence trends of ovarian cancer and relative rates by histologic subtype. Accordingly, we evaluated trends in ovarian cancer incidence overall (1973-1977 to 2003-2007) and by histologic subtype (1988-1992 to 2003-2007) using volumes IV-IX of the Cancer Incidence in Five Continents database (CI5plus) and CI5X (volume X) database. Annual percent changes were calculated for ovarian cancer incidence trends, and rates of histologic subtypes for individual countries were compared to overall international incidence. Ovarian cancer incidence rates were stable across regions, although there were notable increases in Eastern/Southern Europe (e.g., Poland: Annual Percent Change (APC) 1.6%, p = 0.02) and Asia (e.g., Japan: APC 1.7%, p = 0.01) and decreases in Northern Europe (e.g., Denmark: APC -0.7%, p = 0.01) and North America (e.g., US Whites: APC -0.9%, p < 0.01). Relative proportions of histologic subtypes were similar across countries, except for Asian nations, where clear cell and endometrioid carcinomas comprised a higher proportion of the rate and serous carcinomas comprised a lower proportion of the rate than the worldwide distribution. Geographic variation in temporal trends of ovarian cancer incidence and differences in the distribution of histologic subtype may be partially explained by reproductive and genetic factors. Thus, histology-specific ovarian cancer should continue to be monitored to further understand the etiology of this neoplasm.
在国际上,卵巢癌是女性中第七大最常被诊断出的癌症,也是癌症死亡的第八大主要原因。卵巢癌发病率因地区而异,尤其是在比较高收入国家和低收入国家时。生殖因素的时间变化以及诊断标准的转变可能影响了卵巢癌的发病率趋势以及按组织学亚型划分的相对发病率。因此,我们使用《五大洲癌症发病率》数据库(CI5plus)的第四至九卷以及CI5X(第十卷)数据库,评估了总体卵巢癌发病率趋势(1973 - 1977年至2003 - 2007年)以及按组织学亚型划分的发病率趋势(1988 - 1992年至2003 - 2007年)。计算了卵巢癌发病率趋势的年度百分比变化,并将各个国家的组织学亚型发病率与国际总体发病率进行了比较。尽管东欧/南欧(例如波兰:年度百分比变化(APC)为1.6%,p = 0.02)和亚洲(例如日本:APC为1.7%,p = 0.01)有显著上升,北欧(例如丹麦:APC为 - 0.7%,p = 0.01)和北美(例如美国白人:APC为 - 0.9%,p < 0.01)有下降,但各地区的卵巢癌发病率总体稳定。除亚洲国家外,各国组织学亚型的相对比例相似,在亚洲国家,透明细胞癌和子宫内膜样癌在发病率中所占比例高于全球分布,而浆液性癌所占比例低于全球分布。卵巢癌发病率的时间趋势的地理差异以及组织学亚型分布的差异可能部分由生殖和遗传因素解释。因此,应继续监测特定组织学类型的卵巢癌,以进一步了解这种肿瘤的病因。